Back to Search Start Over

First-line nivolumab (anti-PD-1) monotherapy in advanced NSCLC: the story of immune checkpoint inhibitors and "the sorcerers apprentice".

Authors :
Schmid-Bindert G
Jiang T
Source :
Translational lung cancer research [Transl Lung Cancer Res] 2015 Jun; Vol. 4 (3), pp. 215-6.
Publication Year :
2015

Details

Language :
English
ISSN :
2218-6751
Volume :
4
Issue :
3
Database :
MEDLINE
Journal :
Translational lung cancer research
Publication Type :
Academic Journal
Accession number :
26207206
Full Text :
https://doi.org/10.3978/j.issn.2218-6751.2015.01.12